Novel Phosphodiesterase 4 Inhibitor FCPR03 Alleviates Lipopolysaccharide-Induced Neuroinflammation by Regulation of the cAMP/PKA/CREB Signaling Pathway and NF-κB Inhibition-Reference-Cited by-同舟云学术

Novel Phosphodiesterase 4 Inhibitor FCPR03 Alleviates Lipopolysaccharide-Induced Neuroinflammation by Regulation of the cAMP/PKA/CREB Signaling Pathway and NF-κB Inhibition

Published:2017-04-27 Issue:1 Volume:362 Page:67-77
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Zou Zheng-Qiang,Chen Jia-Jia,Feng Hong-Fang,Cheng Yu-Fang,Wang Hai-Tao,Zhou Zhong-Zhen,Guo Hai-Biao,Zheng Wenhua,Xu Jiang-Ping

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference52 articles.

1. Neural and Immune Mechanisms in the Pathogenesis of Parkinson’s Disease

2. Regulation of tumour necrosis factor signalling: live or let die

3. Roflumilast inhibits the release of chemokines and TNF-α from human lung macrophages stimulated with lipopolysaccharide;Buenestado;Br J Pharmacol,2012

4. The Yin and Yang of Microglia

5. Neuroinflammation - using big data to inform clinical practice;Dendrou;Nat Rev Neurol,2016

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of 7-alkoxybenzofurans as PDE4 inhibitors with hepatoprotective activity in D-GalN/LPS-induced hepatic sepsis;European Journal of Medicinal Chemistry;2024-09

2. Beyond PDE4 inhibition: A comprehensive review on downstream cAMP signaling in the central nervous system;Biomedicine & Pharmacotherapy;2024-08

3. Mechanistic Insights of Neuroprotective Efficacy of Verapamil-Loaded Carbon Quantum Dots against LPS-Induced Neurotoxicity in Rats;International Journal of Molecular Sciences;2024-07-16

4. Targeting phosphodiesterase 4 as a potential therapy for Parkinson’s disease: a review;Molecular Biology Reports;2024-04-15

5. Hypersampsonone H attenuates ulcerative colitis via inhibition of PDE4 and regulation of cAMP/PKA/CREB signaling pathway;International Immunopharmacology;2024-02